COA of Formula: C10H11NOOn March 17, 1998, Ruf, Armin; de Murcia, Gilbert; Schulz, Georg E. published an article in Biochemistry. The article was 《Inhibitor and NAD+ Binding to Poly(ADP-ribose) Polymerase As Derived from Crystal Structures and Homology Modeling》. The article mentions the following:
Inhibitors of poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) are of clin. interest because they have potential for improving radiation therapy and chemotherapy of cancer. The refined binding structures of four such inhibitors are reported together with the refined structure of the unligated catalytic fragment of the enzyme. Following their design, all inhibitors bind at the position of the nicotinamide moiety of the substrate NAD+. The observed binding mode suggests inhibitor improvements that avoid other NAD+-binding enzymes. Because the binding pocket of NAD+ has been strongly conserved during evolution, the homol. with ADP-ribosylating bacterial toxins could be used to extend the bound nicotinamide, which is marked by the inhibitors, to the full NAD+ mol. In addition to this study using 5-Methyl-3,4-dihydroisoquinolin-1(2H)-one, there are many other studies that have used 5-Methyl-3,4-dihydroisoquinolin-1(2H)-one(cas: 129075-56-5COA of Formula: C10H11NO) was used in this study.
5-Methyl-3,4-dihydroisoquinolin-1(2H)-one(cas: 129075-56-5) belongs to isoquinoline.COA of Formula: C10H11NO Isoquinoline is a structural isomer of quinoline, and quinoline derivatives are fused ring compounds of pyridine and benzene rings, which have antiseptic, antipyretic and anti-cyclic properties, and can be used as antimalarial drugs and for the preparation of other antimalarial medicine.
Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem